Medical Laboratory Practice
12 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Jenny Jones
Scoop.it!

Effects of daily iron supplementation in primary-school–aged children ... - CMAJ

Effects of daily iron supplementation in primary-school–aged children ...
more...
No comment yet.
Scooped by Jenny Jones
Scoop.it!

Nature Study Points to New Strategy for Treating Acute Myeloid Leukemia - HealthCanal.com

Nature Study Points to New Strategy for Treating Acute Myeloid Leukemia - HealthCanal.com | Medical Laboratory Practice | Scoop.it
Nature Study Points to New Strategy for Treating Acute Myeloid Leukemia HealthCanal.com He is a co-author of the collaborative multicenter study, together with Lan Wang, Ph.D., assistant professor of biochemistry and molecular biology at the Miller...
more...
No comment yet.
Rescooped by Jenny Jones from Breast Cancer News
Scoop.it!

Entinostat plus exemestane improved outcomes in advanced ER-positive breast cancer | Hematology Oncology

Entinostat plus exemestane improved outcomes in advanced ER-positive breast cancer | Hematology Oncology | Medical Laboratory Practice | Scoop.it
Hematology Oncology | The addition of entinostat to exemestane improved clinical outcomes in postmenopausal women with ER-positive advanced breast cancer that progressed on nonsteroidal aromatase inhibitors, according to results of a phase 2 study.

Via Susan Zager
more...
No comment yet.
Rescooped by Jenny Jones from Business Market Research Reports
Scoop.it!

Competing in the US Point-of-Care Diagnostic Testing Market – RnR Market Research

Competing in the US Point-of-Care Diagnostic Testing Market – RnR Market Research | Medical Laboratory Practice | Scoop.it

This new report provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.

 

Rationale

 

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

 

Market Segmentation Analysis

 

- Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing

- Physician Offices/Group Practices

- Emergency Rooms

- Operating/Recovery Suites

- ICUs/CCUs

- Cancer Clinics

- Ambulatory Care Centers

- Surgery Centers

- Nursing Homes

- Birth Centers

 

Complete report available @ http://www.rnrmarketresearch.com/competing-in-the-us-point-of-care-diagnostic-testing-market-market-report.html

 

and by test category:

- Routine and Special Chemistry

- Microbiology/Infectious Diseases

- Hematology

- Flow Cytometry

- Coagulation

- Immunoproteins

- Drugs of Abuse

- TDM

- Endocrine Function

- Tumor Markers

 

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

 

Request a Sample Copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=98828

 

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics,features and selling prices.

 

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

 

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

 

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

 

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group’s proprietary data files.

 

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98828


Via MarketResearchView
more...
No comment yet.
Rescooped by Jenny Jones from Immunology
Scoop.it!

Dendritic Cell Development: A Choose-Your-Own-Adventure Story

Dendritic Cell Development: A Choose-Your-Own-Adventure Story | Medical Laboratory Practice | Scoop.it
Advances in Hematology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of hematology.

Via Gilbert C FAURE
more...
No comment yet.
Rescooped by Jenny Jones from Immunology
Scoop.it!

Termites create their own antibiotics - ABC Science Online

Termites create their own antibiotics - ABC Science Online | Medical Laboratory Practice | Scoop.it
ABC Science Online
Termites create their own antibiotics
ABC Science Online
First, termites possess an innate immunity, due to their biochemistry, which wards off bodily intruders, such as bacteria and pesticides.

Via Gilbert C FAURE
more...
Scooped by Jenny Jones
Scoop.it!

Federal And State Governments Lend Support To Cord Blood Banking - PR Newswire (press release)

Federal And State Governments Lend Support To Cord Blood Banking PR Newswire (press release) The most recent development happened on May 16th when the New York State Senate introduced a bill to create a public umbilical cord blood banking program...
more...
No comment yet.
Scooped by Jenny Jones
Scoop.it!

New test improved prostate cancer risk assessment - Healio

New test improved prostate cancer risk assessment - Healio | Medical Laboratory Practice | Scoop.it
New test improved prostate cancer risk assessment Healio A new genomic screening test significantly improved the ability to predict disease aggressiveness in patients at risk for prostate cancer, according to results presented at the American...
more...
No comment yet.
Rescooped by Jenny Jones from Amazing Science
Scoop.it!

Lamin A and Processing Enzyme ZMPSTE24 Linked to Progeria and 3D Crystal Structure Finally Revealed

Lamin A and Processing Enzyme ZMPSTE24 Linked to Progeria and 3D Crystal Structure Finally Revealed | Medical Laboratory Practice | Scoop.it

A decade ago, Francis Collin's research lab at NIH helped discover the cause of the Hutchinson-Gilford progeria syndrome: a mutation in the lamin-A gene. Just a single letter substitution in the genetic code (C to T) creates a toxic version of the protein. The abnormal protein is missing a segment, and is no longer digestible by an enzyme called ZMPSTE24—essentially a molecular scissors. Without that final snip, the lamin-A protein causes molecular havoc.More recently, children who are completely missing the ZMPSTE24 enzyme have been identified, and they have an even more severe form of progeria called “restrictive dermopathy”. Many questions remain but now we are able to get a close up of ZMPSTE24 and understand how, and where, it normally modifies lamin-A.

 

Using x-ray crystallography, a team based at the UK’s University of Oxford figured out the enzyme’s molecular structure [2, 3]. A cross section of the 3D structure (seen above) reveals a cavernous inner chamber where the authors believe the final snip of lamin-A takes place. It also shows us how mutations in ZMPSTE24, which inhibit lamin-A processing, can also lead to these rare aging disorders.

 

Knowing ZMPSTE24’s structure will help us better understand its clipping functions. It could also shed light on how this enzyme works in the normal aging processes—as well as in the accelerated aging of progeria. Ultimately, we hope it will also inform drug development for this devastating disease.

 

Video Link: http://www.youtube.com/watch?v=7RHhRqDlImg

 

References:

[1] Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Nature. 2003 May 15;423(6937):293-8. Epub 2003 Apr 25.

 

[2] The structural basis of ZMPSTE24-dependent laminopathies. Quigley A, Dong YY, Pike AC, Dong L, Shrestha L, Berridge G, Stansfeld PJ, Sansom MS, Edwards AM, Bountra C, von Delft F, Bullock AN, Burgess-Brown NA, Carpenter EP. Science. 2013 Mar 29;339(6127):1604-7.

 

[3] Biochemistry. A protease for the ages. Michaelis S, Hrycyna CA. Science. 2013 Mar 9;339(6127):1529-30.

 


Via Dr. Stefan Gruenwald
more...
Center for Accessible Living NKY's curator insight, June 4, 2013 10:42 AM

With this knowledge, we can hope that drug treatments and genetic treatments may not be far behind.